2025 International Congress Archives - Page 166 of 181

The role of serotonergic mechanisms in the formation of levodopa-induced drug-induced dyskinesias in Parkinson’s disease

D. Pulatova, F. Saidvaliev (Tashkent, Uzbekistan)
The Role of Sex in Cognitive Impairment, Depression, Anxiety, Hallucinations, Disease Severity and Sleep Disorder Symptoms in Parkinson’s Disease: A Mexican Cohort Study

A. Fierro-Ruiz, A. Solari-Capra, A. Steven-Garcia, P. Reyes-Perez, A. Lázaro-Figueroa, E. Morelos Figaredo, C. Guerra-Galicia, I. Estrada-Bellmann, K. Salinas-Barboza, Y. Matuk-Pérez, N. Gandarilla-Martínez, U. Caballero-Sánchez, P. Montes-Alcantara, V. Flores-Ocampo, I. Espinoza-Mendez, A. Zayas-Del-Mora, E. Gaspar-Martinez, E. Waldo, T. Leal, M. Inca-Martinez, I. Mata, S. Alcauter, A. Medina-Rivera, A. Ruiz-Contreras (Querétaro, Mexico)
The Role of Simulation-Based Learning in Enhancing Clinical Skills for Managing Parkinson’s Disease in Medical Education: A Systematic Review

A. Elsayed, A. Abdelsalhin, M. Mustafa, N. Elmestkawy, O. Hafez, N. Abdeltawab, M. Alomari, M. M. Elsayed (Mansoura, Egypt)
The Role of the Immune System in Dystonia: Insights from HLA genotyping

M. Lindloge, L. Scorr, B. Laabs, D. Ellinghaus, A. Franke, H. Jinnah, C. Klein, K. Lohmann (Altanta, USA)
The Role of α7 Nicotinic Acetylcholine Receptor in Mitochondrial Homeostasis and Neuroprotection

I. Goglia, Z. Landoulsi, P. May, M. Tziortziou, S L. Pereira, A. Grünewald (Esch-sur Alzette, Luxembourg)
The Sedentary Index (SI) for Daily Life Activity Monitoring in Progressive Supranuclear Palsy (PSP)

M. Dale, C. Silva-Batista, A. Ragothaman, Z. Nhem, A. Lawston, G. Harker, D. Maxwell, C. Speirs, D. Loudon, M. Mancini (Portland, USA)
The Severity and Burden of Movement Disorder Symptomology in Patients with Cerebrotendinous Xanthomatosis: A US-based Survey

F. Eichler, R. Hanke, C. Higuera, B. Wishart, B. Blanchard, G. Bryce, N. Odedara, S. Laurie, R. Dutta, J. Terner-Rosenthal, R. Aguilar, T. Pramparo, J. Pickford (Boston, USA)
The sphingolipid Lyso-Gb3, a biomarker for the lysosomal storage disorder Fabry Disease, is significantly elevated in blood from patients with Parkinson’s Disease

C. Beetz, C. Cozma, M. Iurascu, S. Fischer, S. Oppermann, K. Kandaswamy, P. Bauer (Rostock, Germany)
The Syn-D Study: Detection of Cutaneous Phosphorylated Alpha-Synuclein and blood P-Tau 217 in Patients with Mild Cognitive Impairment

C. Gibbons, T. Levine, B. Bellaire, R. Freeman (Boston, USA)
The Syn-Sleep Study Detection of Cutaneous Phosphorylated Alpha-Synuclein in REM Sleep Behavior Disorder

T. Levine, B. Bellaire, R. Freeman, C. Gibbons (scottsdale, USA)